COVMIP Study
Research type
Research Study
Full title
A feasibility study of a universal neonatal and maternal screening programme for SARS-CoV-2.
IRAS ID
285645
Contact name
Katharine E M McDevitt
Contact email
Sponsor organisation
NORTH WEST ANGLIA FOUNDATION TRUST
Duration of Study in the UK
1 years, 0 months, 1 days
Research summary
SARS-CoV-2 (COVID-19) was declared a pandemic by the World Health Organisation in March 2020 [1] with over 9 million cases and more than 450 thousand deaths worldwide. There is a need to collect data globally about the natural history of this SARS-Cov-2 infection. This includes the effect this infection has on pregnancy as it will affect thousands of pregnant women globally.
It is essential that research is undertaken so that it can inform us on the management, treatment and preventative strategies of this infection.
There is considerable uncertainty regarding the possibility of infection to the newborns from their mothers and most literature to date seems to suggest that vertical transmission is unlikely even in symptomatic COVID-19 positive mothers. However, locally we have found babies to be positive at birth. In order to learn more about the natural history of SARS-CoV-2 in all pregnant women (symptomatic and asymptomatic) and their neonates we propose for a feasibility study to ascertain if it is acceptable to women to have universal screening completed in not only themselves but their infant and placenta. We will then assess the acceptability of antibody testing in the mother and neonate if any of the swabs are positive for SAR-CoV-2.REC name
South Central - Oxford B Research Ethics Committee
REC reference
20/SC/0285
Date of REC Opinion
17 Jul 2020
REC opinion
Unfavourable Opinion